UBS Group’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$625K Hold
4,788
– – ﹤0.01% 6045
2026
Q2
$729K Buy
+4,788
New +$798K ﹤0.01% 5977
2025
Q3
– Sell
-6,000
Closed -$1.89M – 10791
2025
Q2
$1.89M Buy
+6,000
New +$1.73M ﹤0.01% 4877
2020
Q1
– Sell
-25,000
Closed -$4.28M – 8295
2019
Q4
$4.28M Buy
+25,000
New +$4.17M ﹤0.01% 2747
2017
Q2
– Sell
-10,000
Closed -$431K – 7904
2017
Q1
$431K Buy
+10,000
New +$429K ﹤0.01% 4142

Other funds holding PODD

UBS Group's PODD Position: Q3 2026 in Review

UBS Group increased its Insulet (PODD) stake by 14% in Q3 2026, buying an estimated $11.4M and bringing the position to 619,378 shares worth $80.8M. The position accounts for 0.01% of the portfolio, ranked #1261.

UBS Group first reported a position in PODD in Q4 2014 and has held it in 48 quarters since. The position peaked at $93.6M in Q1 2026. 694 funds tracked by Wall St. Rank hold PODD as of Q3 2026.

  • UBS Group held 619,378 shares of Insulet worth $80.8M as of Q3 2026.
  • UBS Group bought 76,348 Insulet shares in Q3 2026, an estimated $11.4M.
  • Insulet made up 0.01% of UBS Group's portfolio in Q3 2026, its #1261 holding.
  • UBS Group first reported a position in Insulet in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Insulet position peaked at $93.6M in Q1 2026.
  • 694 funds tracked by Wall St. Rank held Insulet as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.